
Executive Director responsible for global market access strategies at SpringWorks Therapeutics. Leading initiatives and aligning value propositions across international markets with emphasis on rare diseases.

SpringWorks is a commercial-stage biopharmaceutical company applying a precision medicine approach to developing and delivering life-changing medicines for people with severe rare diseases and cancer.Founded in 2017, SpringWorks has a diversified targeted oncology pipeline spanning solid tumors and hematological cancers, including clinical trials in rare tumor types and highly prevalent, genetically defined cancers.
Browse and apply for open jobs at SpringWorks Therapeutics.

Executive Director responsible for global market access strategies at SpringWorks Therapeutics. Leading initiatives and aligning value propositions across international markets with emphasis on rare diseases.

Global Brand Director at SpringWorks Therapeutics improving lives of patients with rare tumors. Overseeing brand strategy, messaging, and campaigns with oncology and rare disease expertise.

Senior Director, leading market access strategy for SpringWorks therapeutic products. Driving value proposition through engagement with key stakeholders in rare disease and oncology space.

Director of Market Insights, Analytics, and Intelligence at SpringWorks Therapeutics. Collaborating with global teams to enhance brand strategies and market insights.

Senior Product Manager at SpringWorks Therapeutics developing marketing strategies for NF1 - PN. Collaborating cross - functionally and supporting HCP engagement to drive product success.

Director of U.S. Marketing leading patient marketing strategies for SpringWorks' TGCT commercial brand. Collaborating cross - functionally to ensure product positioning and market success in rare tumors.

Senior Director, Brand Lead overseeing marketing strategy for OGSIVEO at SpringWorks Therapeutics. Leading cross - functional teams to drive commercial success in rare tumor treatment.

Lead preparation of regulatory clinical documents and manage Veeva workflows at SpringWorks Therapeutics, a commercial - stage biopharma focused on rare tumors.